Long-Term Liabilities: The sum of all non-current liabilities.
Phio Pharmaceuticals Corp. (PHIO) Long-Term Liabilities data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-2.17M |
|
-- |
|
-- |
|
$2.31M |
|
$-2.31M |
|
$0.14M |
|
$-2.17M |
|
$-2.17M |
|
$-2.17M |
|
$-2.17M |
|
$-2.17M |
|
$-2.17M |
|
$-2.31M |
|
$-2.31M |
|
4.79M |
|
4.79M |
|
$-0.45 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$11.29M |
|
$0.01M |
|
$0.01M |
|
$11.30M |
|
$1.21M |
|
-- |
|
|
Long-Term Liabilities |
-- |
$1.21M |
|
$10.10M |
|
$10.10M |
|
$10.10M |
|
4.80M |
|
| Cash Flow Statement Financials | |
$-3.81M |
|
$-0.01M |
|
$9.21M |
|
$5.38M |
|
$10.78M |
|
$5.39M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
9.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.82M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-21.46% |
|
-21.46% |
|
-19.17% |
|
-21.46% |
|
$2.10 |
|
$-0.80 |
|
$-0.80 |
|